Generalized white appearance of the oral mucosa

Journal of the American Dental Association

Volumn 141, Issue 7, 2010, Pages 867-869

  Lerman, Mark A ^a,b   Treister, Nathaniel S ^a,b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATINOCYTE GROWTH FACTOR; RECOMBINANT PROTEIN;

CASE REPORT; CHEMICALLY INDUCED; DRUG EFFECTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOSIS; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; MUCOSITIS; PATHOLOGY; STOMATITIS;

FIBROBLAST GROWTH FACTOR 7; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; MUCOSITIS; RECOMBINANT PROTEINS; STOMATITIS; TRANSPLANTATION CONDITIONING;

EID: 77954906080     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2010.0285     Document Type: Article

References (10)

1. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008; 52(1): 61-77, viii.
2. Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 2007; 5(9 suppl 4): 3-11.
3. Pasquini M, Wang Z, Schneider L. Current use and outcome of hematopoietic stem cell transplantation, part I: CIBMTR summary slides, 2007. CIBMTR Newsletter 2007; 13(2): 5-9. "www.cibmtr.org/ReferenceCenter/Newsletters/ PDF/Newsletter-Dec2007.pdf. Accessed May 14, 2010.
4. McDonnell AM, Lenz KL. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother 2007; 41(1): 86-94. (Pubitemid 46145961)
5. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351(25): 2590-2598. (Pubitemid 39628580)
6. Elting LS, Shin YC, Stiff PJ, et al. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Biol Blood Marrow Transplant 2007; 13(7): 806-813.
7. Beaven AW, Shea TC. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant. Drugs Today (Bare) 2007; 43(7): 461-473.
8. Whitt JC, Dunlap CL, Martin KF. Oral Hodgkin lymphoma: a wolf in wolfs clothing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104(5): e45-51.
9. Jorgenson RJ, Levin S. White sponge nevus. Arch Dermatol 1981; 117(2): 73-76.
10. Scully C, Carrozzo M. Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 2008; 46(1): 15-21. (Pubitemid 350266149)